FDA Authorizes LabCorp's At-Home COVID-19 Test Kit
Shares of Laboratory Corporation of America Holdings (NYSE: LH) headed higher Tuesday on news that the FDA has granted emergency use authorization for its at-home test kit for COVID-19.
The test kit includes a nasal swab that a person can use to take their own sample, which they then mail to LabCorp for processing. Patients in most states will be able to buy the test kit online from the company's online portal, but first, they will need an order from a healthcare professional, which they can get after filling out a questionnaire. The ability to self-administer the test allows people to avoid the risk of transmitting the virus at test sites, and reduces the demand for personal protective equipment for clinicians.
Image source: Getty Images.
Source Fool.com
